Nexalin Technology, Inc.

8 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

May 2029

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Jul 16, 2027
The maintenance fee for Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System (US 11,872,397) comes due Jul 16, 2027. Unpaid by Jan 18, 2028, it lapses early.
1 fee due Oct 2, 2027
The maintenance fee for Transcranial alternating current dynamic frequency stimulation method for anxiety, depression, and insomnia (ADI) (US 11,944,806) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Patent	Title	Status	Expires	Confidence
US 7,769,463	Multi-channel electrostimulation apparatus and method In force (reinstated) Term ends May 16, 2029 · From the USPTO record	In force (reinstated)	Term ends May 16, 2029	From the USPTO record
US D1,073,092	Transcranial electro-stimulation device In force Term ends Apr 29, 2040 · From the USPTO record	In force	Term ends Apr 29, 2040	From the USPTO record
US D1,092,758	Transcranial electro-stimulation device In force Term ends Sep 9, 2040 · From the USPTO record	In force	Term ends Sep 9, 2040	From the USPTO record
US 12,011,591	Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method for Alzheimers and Dementia In force Term ends Dec 9, 2040 · High confidence	In force	Term ends Dec 9, 2040	High confidence
US 11,872,397	Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System In force Ends no later than Jun 3, 2041 · Medium confidence	In force	Ends no later than Jun 3, 2041	Medium confidence
US 12,263,336	Alternating current dynamic frequency stimulation system and method for opioid use disorder (OUD) and substance use disorder (SUD) In force Term ends Dec 31, 2041 · From the USPTO record	In force	Term ends Dec 31, 2041	From the USPTO record
US 12,629,519	Transcranial Alternating Current Dynamic Frequency Stimulation Method for Anxiety, Depression, and Insomnia (ADI) In force Ends no later than Feb 25, 2042 · Low confidence	In force	Ends no later than Feb 25, 2042	Low confidence
US 11,944,806	Transcranial alternating current dynamic frequency stimulation method for anxiety, depression, and insomnia (ADI) In force Term ends Jul 20, 2042 · From the USPTO record	In force	Term ends Jul 20, 2042	From the USPTO record

Also on record, not counted in the 8: 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending

List them